|
|
Strong prolyl hydroxylase domain 1 expression predicts poor outcome in radiotherapy-treated patients with classical Hodgkin’s lymphoma |
|---|---|
| Author: | Bur, Hamid1,2; Haapasaari, Kirsi-Maaria2,3; Turpeenniemi-Hujanen, Taina1,2; |
| Organizations: |
1Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland 2Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland 3Department of Pathology, Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland
4Department of Oncology, Kuopio University Hospital, Kuopio, Finland
5Cancer Center, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland 6Department of Pathology and Forensic Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland |
| Format: | article |
| Version: | published version |
| Access: | open |
| Online Access: | PDF Full Text (PDF, 0.3 MB) |
| Persistent link: | http://urn.fi/urn:nbn:fi-fe2019110136209 |
| Language: | English |
| Published: |
International Institute of Anticancer Research,
2018
|
| Publish Date: | 2019-11-01 |
| Description: |
AbstractBackground: Hypoxia-inducible factors (HIFs) and prolyl hydroxylase domain (PHD) proteins control cellular oxygen homeostasis and a wide range of other processes. Materials and Methods: We immunohistochemically assessed the expression of HIF1α, HIF2α, PHD1, PHD2 and PHD3 in 115 cases of classical Hodgkin’s lymphoma, all treated in the first line with doxorubicin, bleomycin, vinblastine and darcabazine (ABVD) chemotherapy. Results: In advanced-stage patients treated with involved-field radiotherapy (IFRT), nuclear HIF1α expression in reactive cellular infiltrate predicted prolonged relapse-free survival (RFS) (p=0.026). Strong cytoplasmic PHD1 expression in Reed–Sternberg cells was associated with poor RFS among patients treated with IFRT and advanced-stage patients treated with ABVD and IFRT (p=0.0028 and p=0.0058, respectively). In Cox regression analysis, PHD1 was a more significant predictor of relapse (risk ratio=18.383; 95% confidence interval(CI)=1.521–222.246; p=0.022) than the International Prognostic Score. Conclusion: HIF and PHD expression appear to be novel prognostic biomarkers in classical Hodgkin’s lymphoma. see all
|
| Series: |
Anticancer research |
| ISSN: | 0250-7005 |
| ISSN-E: | 1791-7530 |
| ISSN-L: | 0250-7005 |
| Volume: | 38 |
| Issue: | 1 |
| Pages: | 329 - 336 |
| DOI: | 10.21873/anticanres.12226 |
| OADOI: | https://oadoi.org/10.21873/anticanres.12226 |
| Type of Publication: |
A1 Journal article – refereed |
| Field of Science: |
3122 Cancers |
| Subjects: | |
| Funding: |
The Finnish Cancer Society, the Finnish Antituberculosis Association for support, Väisänen Fund in Terttu Foundation of North-Finland Healthcare Support. |
| Copyright information: |
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. Self-archived with the kind permission by the publisher. |